LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 131 pages found matching glaxo- Lights, Action, Camera on Whistleblowers in 2011?
Jan-8-11 Washington, DC For many people, Cheryl Eckard became a celebrity after 60 minutes profiled the whistleblower in a sensational story that likely started the year off badly for GlaxoSmithKline (GSK). Lawyers and Settlements has been watching the qui tam whistleblower lawsuit unfold since last October , when we reported on the whistleblower lawsuit a... - Will We Ever Know for Sure if Paxil Causes Paxil Birth Defects?
Dec-29-10 Toronto, Ontario The debate over Paxil side effects as they relate to infants born with heart defects continues to be hotly contested—especially given the need for some women to remain on antidepressants on a consistent basis for depression. So do you stop an antidepressant like Paxil during pregnancy and risk harming the mother? Or do you continue a... - Paxil Suit Is Still On!
Dec-24-10 Philadelphia, PA From the point of view of the attorneys for the plaintiff, everything seemed to be on track as the product liability trial against Glaxo Smith Kline (GSK) got under way. Anna Blyth had been born with a heart defect, a defect that could be easily linked to the fact that her mother had been prescribed Paxil , a GSK drug used to help patie... - Details Still Sparse on Fixodent Zinc Poisoning
Dec-6-10 Cincinatti, OH The manufacturer of Fixodent denture adhesive continues to resist following the path blazed by rival Poligrip, after GlaxoSmithKline (Glaxo) decided to remove zinc from its denture cream formulation. That announcement came on February 18, 2010. Almost a year later, Procter & Gamble (P&G) has not advanced a similar decision, and i... - Paxil Birth Defect Trial Tossed Out of Court
Dec-1-10 Summerville, SC It was a heartbreaking end to a Paxil birth defects trial in Philadelphia, after a judge ended the proceedings at about the midway point, finding for GlaxoSmithKline (Glaxo), the defendant. The lawsuit, the first Paxil trial to be undertaken since Glaxo agreed in July to settle 800 cases by paying out more than $1 billion, attempted to... - Former Glaxo Executive Indicted
Nov-10-10 Durham, NC A long-promised crackdown on pharmaceutical executives accused of potential wrongdoing is gaining momentum with the indictment yesterday of a former vice president and legal counsel of GlaxoSmithKline (Glaxo). While the pharmaceutical giant is headquartered in the UK, its US operations are based in North Carolina. The New York Times reporte... - Will New Potential Benefit Breathe New Life into Avandia?
Nov-4-10 Vancouver, BC In what will likely serve to only complicate the continuing debate over the safety and efficacy of Avandia , new research is suggesting that the class of diabetes drugs to which Avandia belongs may both prevent, and contain lung cancer. The findings were presented yesterday (November 2nd) at the annual meeting of the American College of Ch... - Glaxo $750 Million Settlement Fourth-Largest in History
Oct-28-10 Boston, MA A whistleblower is $96 million richer after bringing a federal False Claims Act (FCA) lawsuit against UK pharmaceutical giant GlaxoSmithKline (Glaxo) over deviations in good manufacturing practices at a former plant in Puerto Rico. In total, Glaxo agreed to pay $750 million in penalties and will plead guilty to a criminal charge in rela... - Fixodent Zinc Poisoning: "They Don't Tell You How Much Is Too Much"
Oct-6-10 Broadview, SK Hedvig Ahlquist, a 56-year-old nurse from Saskatchewan, is leading a class-action lawsuit in Canada against two denture adhesive manufacturers that could potentially extend across the entire Great White North. According to the Canadian Press ( CP ), lawyers have filed statements of claim against GlaxoSmithKline and Proctor and Gamble in... - British Medical Journal: Pull Avandia from Market
Sep-20-10 London, England The British Medical Journal recently said that the diabetes drug Avandia , made by GlaxoSmithKline, should be pulled from the market and, in fact, should never have been licensed at all. The journal found that the panel that had approved the medication prior to its entry into the European Union market in 2000 had concerns about pote... - Average Paxil Birth Defect Settlement $1.2 Million
Aug-28-10 London, UK While no amount of money can adequately compensate for a life-altering birth defect allegedly caused by or linked to the use of the antidepressant Paxil, the average settlement in a Paxil birth defect lawsuit appears to be in excess of $1.2 million for each family involved. The Newark Star-Ledger noted in July that Paxil manufacturer GlaxoSm... - Avandia's Fate is Sealed, Says Doctor. "The Drug is Done"
Aug-5-10 Washington, DC While the US Food and Drug Administration (FDA) has yet to decide on the fate of Avandia in the wake of an expert panel's various recommendations and positions at a summit held in July, some in the medical community say that given the Avandia risks —including heart attack, liver failure and bone fractures—the disappearance of... - Glaxo Settles Paxil Side Effects Lawsuits, Average Settlement $1.2 Million
Jul-28-10 Newark, NJ GlaxoSmithKline (Glaxo), the largest drug manufacturer in the UK, is believed to have paid out about $1 billion to settle various Paxil lawsuits since the drug first came onto the market in 1993. Earlier this month it was announced that Glaxo has agreed to pay another $1 billion to settle more than 800 outstanding cases alleging Paxil birth de... - FDA Medical Reviewer Slams RECORD Trial Conclusions, Casting Further Doubt on Avandia
Jul-9-10 Washington, DC The US Food and Drug Administration (FDA) today stated through a posting on the official FDA website that GlaxoSmithKline (Glaxo), the manufacturer of Avandia , may have misinterpreted crucial details of a study that it said had vindicated Avandia and found the Type 2 diabetes drug to be safe. A medical reviewer with the FDA said that,... - Paxil Birth Defect Cases Continue on the Road to Settlement
Jun-29-10 Washington, DC Expectant mothers who suffer from depression face a difficult decision: Paxil and other antidepressants have been linked to an increased risk of birth defects, yet many pregnant women are unable to manage their depression without medication. While the debate rages on over the best course of action, it seems that the US Food and Drug Admi... - More Damning News about Avandia One Month before FDA Review
Jun-13-10 Washington, DC A well-known and outspoken reviewer for the US Food and Drug Administration (FDA) has released study data suggesting that type 2 diabetes drug Avandia increases the risk of heart attack by 25 percent, the risk of stroke by 27 percent and the risk of death by as much as 17 percent when compared with rival diabetes drug Actos, manufactured... - More Avandia Lawsuits Settled
Jun-2-10 Philadelphia, PA Reuters reported yesterday that GlaxoSmithKline has settled additional Avandia lawsuits . The lawsuits alleged that GlaxoSmithKline, the maker of Avandia, failed to adequately warn patients about the risk of serious side effects. A GlaxoSmithKline spokesperson announced the settlement on June 1, 2010, but did not give further detail... - Officials Consider Stopping Avandia Study
Apr-20-10 Washington, DC The US Food and Drug Administration (FDA) is considering halting a safety trial of competing diabetes medications Avandia , made by GlaxoSmithKline (Glaxo), and Actos, by Takeda Pharmaceutical Co. Some experts have said it is unethical to compare Avandia, a drug known to increase the risk of heart attacks, with a drug that is reportedly s... - Paxil Off-Label Use to Be Focus of Heart Defects Trial
Apr-18-10 Washington, DC Paxil manufacturer GlaxoSmithKline (Glaxo) faces hundreds of Paxil lawsuits alleging that the antidepressant causes birth defects. Next up at the plate is Delaney Novak, a little girl born on April 4, 2002 with heart defects. In June, her parents Laura and Derek will contend that misconduct on the part of Glaxo over safety warnings for P... - The Faces Behind the Paxil Birth Defect Headlines
Feb-20-10 Philadelphia, PA Stories about Paxil side effects are always accompanied by headlines that contains words and numbers—but not necessarily faces. The people behind the headlines are too often overshadowed by the statistics. There is Meah Gibson, the little girl who was born with a hole in her heart in 2005. It was eventually corrected by surger...